|
|
| | LDN-212320 Basic information |
| Product Name: | LDN-212320 | | Synonyms: | LDN-212320;LDN-0212320;3-((2-methylbenzyl)thio)-6-(pyridin-2-yl)pyridazine;LDN/OSU-0212320;LDN-0212320;OSU-0212320;LDN/OSU-0212320;(3-[(2-methylbenzyl)sulfenyl]-6-(pyridine-2-yl)pyridazine);3-[[(2-Methylphenyl)methyl]thio]-6-(2-pyridinyl)-pyridazine;OSU-0212320 | | CAS: | 894002-50-7 | | MF: | C17H15N3S | | MW: | 293.39 | | EINECS: | | | Product Categories: | | | Mol File: | 894002-50-7.mol |  |
| | LDN-212320 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 50 mg/mL (170.42 mM; Need ultrasonic) | | form | Powder |
| | LDN-212320 Usage And Synthesis |
| Uses | LDN 212320 is a small molecule activator of glutamate transporter EAAT2 translation, which provides neuroprotection and shows potential for the therapeutic treatment of neurodegenerative diseases. |
| | LDN-212320 Preparation Products And Raw materials |
|